Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives

Gastric cancer (GC) is a malignant tumor that originates from the epithelium of the gastric mucosa. The latest global cancer statistics show that GC ranks fifth in incidence and fourth in mortality among all cancers, posing a serious threat to public health. While early-stage GC is primarily treated...

Full description

Bibliographic Details
Main Authors: Jiahua Liu, Qihang Yuan, Hui Guo, Hewen Guan, Zhijun Hong, Dong Shang
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332224001914
_version_ 1797248451549855744
author Jiahua Liu
Qihang Yuan
Hui Guo
Hewen Guan
Zhijun Hong
Dong Shang
author_facet Jiahua Liu
Qihang Yuan
Hui Guo
Hewen Guan
Zhijun Hong
Dong Shang
author_sort Jiahua Liu
collection DOAJ
description Gastric cancer (GC) is a malignant tumor that originates from the epithelium of the gastric mucosa. The latest global cancer statistics show that GC ranks fifth in incidence and fourth in mortality among all cancers, posing a serious threat to public health. While early-stage GC is primarily treated through surgery, chemotherapy is the frontline option for advanced cases. Currently, commonly used chemotherapy regimens include FOLFOX (oxaliplatin + leucovorin + 5-fluorouracil) and XELOX (oxaliplatin + capecitabine). However, with the widespread use of chemotherapy, an increasing number of cases of drug resistance have emerged. This article primarily explores the potential mechanisms of chemotherapy resistance in GC patients from five perspectives: cell death, tumor microenvironment, non-coding RNA, epigenetics, and epithelial-mesenchymal transition. Additionally, it proposes feasibility strategies to overcome drug resistance from four angles: cancer stem cells, tumor microenvironment, natural products, and combined therapy. The hope is that this article will provide guidance for researchers in the field and bring hope to more GC patients.
first_indexed 2024-03-07T22:55:50Z
format Article
id doaj.art-fbeff93da2a748b5a5abb403f1436e29
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-04-24T20:14:48Z
publishDate 2024-04-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-fbeff93da2a748b5a5abb403f1436e292024-03-23T06:22:43ZengElsevierBiomedicine & Pharmacotherapy0753-33222024-04-01173116310Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectivesJiahua Liu0Qihang Yuan1Hui Guo2Hewen Guan3Zhijun Hong4Dong Shang5First Affiliated Hospital of Dalian Medical University, Dalian, ChinaFirst Affiliated Hospital of Dalian Medical University, Dalian, ChinaFirst Affiliated Hospital of Dalian Medical University, Dalian, ChinaCorresponding authors.; First Affiliated Hospital of Dalian Medical University, Dalian, ChinaCorresponding authors.; First Affiliated Hospital of Dalian Medical University, Dalian, ChinaCorresponding authors.; First Affiliated Hospital of Dalian Medical University, Dalian, ChinaGastric cancer (GC) is a malignant tumor that originates from the epithelium of the gastric mucosa. The latest global cancer statistics show that GC ranks fifth in incidence and fourth in mortality among all cancers, posing a serious threat to public health. While early-stage GC is primarily treated through surgery, chemotherapy is the frontline option for advanced cases. Currently, commonly used chemotherapy regimens include FOLFOX (oxaliplatin + leucovorin + 5-fluorouracil) and XELOX (oxaliplatin + capecitabine). However, with the widespread use of chemotherapy, an increasing number of cases of drug resistance have emerged. This article primarily explores the potential mechanisms of chemotherapy resistance in GC patients from five perspectives: cell death, tumor microenvironment, non-coding RNA, epigenetics, and epithelial-mesenchymal transition. Additionally, it proposes feasibility strategies to overcome drug resistance from four angles: cancer stem cells, tumor microenvironment, natural products, and combined therapy. The hope is that this article will provide guidance for researchers in the field and bring hope to more GC patients.http://www.sciencedirect.com/science/article/pii/S0753332224001914Gastric cancerDrug resistanceMechanismPerspectives
spellingShingle Jiahua Liu
Qihang Yuan
Hui Guo
Hewen Guan
Zhijun Hong
Dong Shang
Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives
Biomedicine & Pharmacotherapy
Gastric cancer
Drug resistance
Mechanism
Perspectives
title Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives
title_full Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives
title_fullStr Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives
title_full_unstemmed Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives
title_short Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives
title_sort deciphering drug resistance in gastric cancer potential mechanisms and future perspectives
topic Gastric cancer
Drug resistance
Mechanism
Perspectives
url http://www.sciencedirect.com/science/article/pii/S0753332224001914
work_keys_str_mv AT jiahualiu decipheringdrugresistanceingastriccancerpotentialmechanismsandfutureperspectives
AT qihangyuan decipheringdrugresistanceingastriccancerpotentialmechanismsandfutureperspectives
AT huiguo decipheringdrugresistanceingastriccancerpotentialmechanismsandfutureperspectives
AT hewenguan decipheringdrugresistanceingastriccancerpotentialmechanismsandfutureperspectives
AT zhijunhong decipheringdrugresistanceingastriccancerpotentialmechanismsandfutureperspectives
AT dongshang decipheringdrugresistanceingastriccancerpotentialmechanismsandfutureperspectives